Glasgow prognostic score predicts efficacy and prognosis in patients with advanced non-small cell lung cancer receiving EGFR-TKI treatment.

Norimitsu Kasahara Hisao ImaiIchiro NaruseYusuke TsukagoshiMie KotakeNoriaki Sunaga Kyoichi KairaToshitaka MaenoTakayuki AsaoTakeshi Hisada

Published in: Thoracic cancer (2020)

The findings presented in this paper will help to identify patients who will be expected to experience limited or no response to EGFR-TKI treatment by using GPS.

Keyphrases

advanced non small cell lung cancer
epidermal growth factor receptor
tyrosine kinase
small cell lung cancer
replacement therapy
smoking cessation